1. Hashimoto, K., 2011. Role of the mTOR signaling pathway in the rapid antidepressant action of ketamine. Expert Rev. Neurother., 11: 33-36.
   PubMed  |  
2. Hashimoto, K., 2011. Can minocycline prevent the onset of Alzheimer's disease. Ann. Neurol., (In Press). .
3. Hashimoto, K., 2010. Brain-derived neurotrophic factor as a biomarker for mood disorders: An historical overview and future directions. Psychiatry Clin. Neurosci., 64: 341-357.
   PubMed  |  
4. Hashimoto, K. and T. Ishima, 2010. A novel target of action of minocycline in NGF-induced neurite outgrowth in PC12 cells: Translation initiation factor eIF4AI. PLoS One, 5: e15430-e15430.
   PubMed  |  
5. Hashimoto, K., 2009. Emerging role of glutamate in the pathophysiology of major depressive disorder. Brain Res. Rev., 61: 105-123.
   CrossRef  |